198 related articles for article (PubMed ID: 33472018)
41. Glassy cell carcinoma of the uterine cervix: 20-year experience from a comprehensive cancer center.
Boustani J; Achkar S; Bertaut A; Genestie C; Gouy S; Pautier P; Morice P; Haie-Meder C; Chargari C
Cancer Radiother; 2021 May; 25(3):207-212. PubMed ID: 33408051
[TBL] [Abstract][Full Text] [Related]
42. Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy.
Turner BC; Knisely JP; Kacinski BM; Haffty BG; Gumbs AA; Roberts KB; Frank AH; Peschel RE; Rutherford TJ; Edraki B; Kohorn EI; Chambers SK; Schwartz PE; Wilson LD
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):77-84. PubMed ID: 9422561
[TBL] [Abstract][Full Text] [Related]
43. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion.
Huguet F; Cojocariu OM; Levy P; Lefranc JP; Darai E; Jannet D; Ansquer Y; Lhuillier PE; Benifla JL; Seince N; Touboul E
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1508-15. PubMed ID: 18676093
[TBL] [Abstract][Full Text] [Related]
44. CALLA: Efficacy and safety of concurrent and adjuvant durvalumab with chemoradiotherapy versus chemoradiotherapy alone in women with locally advanced cervical cancer: a phase III, randomized, double-blind, multicenter study.
Mayadev J; Nunes AT; Li M; Marcovitz M; Lanasa MC; Monk BJ
Int J Gynecol Cancer; 2020 Jul; 30(7):1065-1070. PubMed ID: 32447296
[TBL] [Abstract][Full Text] [Related]
45. Role of vaginal brachytherapy boost following adjuvant external beam radiotherapy in cervical cancer: Turkish Society for Radiation Oncology Gynecologic Group Study (TROD 04-002).
Gultekin M; Beduk Esen CS; Balci B; Alanyali S; Akkus Yildirim B; Guler OC; Yuce Sari S; Ergen SA; Sahinler I; Alsan Cetin I; Onal C; Yildiz F; Ozsaran Z
Int J Gynecol Cancer; 2021 Feb; 31(2):185-193. PubMed ID: 32998860
[TBL] [Abstract][Full Text] [Related]
46. The impact of adjuvant hysterectomy on survival outcomes of patients with locally advanced cervical cancer: A network meta-analysis.
Pergialiotis V; Bellos I; Douligeris A; Thomakos N; Rodolakis A; Haidopoulos D
Eur J Surg Oncol; 2022 Jan; 48(1):261-267. PubMed ID: 34548217
[TBL] [Abstract][Full Text] [Related]
47. Radical radiotherapy in patients with cervix uteri carcinoma: experience of Ondokuz Mayis University.
Serarslan A; Gursel B; Meydan D; Ozbek Okumus N
BMC Cancer; 2019 Dec; 19(1):1208. PubMed ID: 31830953
[TBL] [Abstract][Full Text] [Related]
48. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
[No Abstract] [Full Text] [Related]
49. Comparison of pelvic and para-aortic lymphadenectomy versus para-aortic lymphadenectomy alone for locally advanced FIGO stage IB2 to IIB cervical cancer using a propensity score matching analysis: Results from the FRANCOGYN study group.
Bendifallah S; de Foucher T; Ouldamer L; Bricou A; Lavoue V; Varinot J; Canlorbe G; Carcopino X; Raimond E; Huguet F; Graesslin O; Touboul C; Collinet P; Huchon C; Daraï E; Ballester M;
Eur J Surg Oncol; 2018 Dec; 44(12):1921-1928. PubMed ID: 30213717
[TBL] [Abstract][Full Text] [Related]
50. Adjuvant Hysterectomy in Patients With Residual Disease After Radiation for Locally Advanced Cervical Cancer: A Prospective Longitudinal Study.
Pervin S; Ruma FI; Rahman K; Ferdous J; Ara R; Abu Syed MM; Goodman A
J Glob Oncol; 2019 Jan; 5():1-7. PubMed ID: 30707665
[TBL] [Abstract][Full Text] [Related]
51. Magnetic resonance imaging during definitive chemoradiotherapy can predict tumor recurrence and patient survival in locally advanced cervical cancer: A multi-institutional retrospective analysis of KROG 16-01.
Lee SW; Lee SH; Kim J; Kim YS; Yoon MS; Jeong S; Kim JH; Lee J; Eom KY; Jeong BK; Sung SY; Lee SJ; Lee JH
Gynecol Oncol; 2017 Nov; 147(2):334-339. PubMed ID: 28935271
[TBL] [Abstract][Full Text] [Related]
52. [The guidelines for diagnostics and treatment of cervical cancer].
Inciūra A; Juozaityte E
Medicina (Kaunas); 2004; 40(4):394-403. PubMed ID: 15111756
[TBL] [Abstract][Full Text] [Related]
53. [Outcomes and prognostic factors of advanced squamous cervical cancer after concurrent chemoradiotherapy].
Binbin T; Lingying W; Manni H; Jusheng A; Ning L
Zhonghua Fu Chan Ke Za Zhi; 2014 May; 49(5):348-54. PubMed ID: 25030731
[TBL] [Abstract][Full Text] [Related]
54. Outcome of patients with incomplete resection after surgery for stage IB2/II cervical carcinoma with chemoradiation therapy.
Uzan C; Vincens E; Balleyguier C; Gouy S; Pautier P; Duvillard P; Haie-Meder C; Morice P
Int J Gynecol Cancer; 2010 Apr; 20(3):379-84. PubMed ID: 20375801
[TBL] [Abstract][Full Text] [Related]
55. Para-aortic plus pelvic lymphadenectomy in locally advanced cervical cancer: A single institutional experience.
Mezquita G; Muruzabal JC; Perez B; Aguirre S; Villafranca E; Jurado M
Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():79-83. PubMed ID: 30889424
[TBL] [Abstract][Full Text] [Related]
56. Matched-case comparison for the role of surgery in FIGO stage Ib1-IIa squamous cell carcinoma of cervix and suspicious para-aortic lymph node metastasis.
Kim HS; Park NH; Wu HG; Cho JY; Chung HH; Kim JW; Song YS; Kim SH; Kang SB
Ann Surg Oncol; 2009 Jan; 16(1):133-9. PubMed ID: 18979134
[TBL] [Abstract][Full Text] [Related]
57. Five-year outcome of concurrent radiotherapy and chemotherapy in Saudi women with locally advanced cervical cancer: single-institution experience.
Al Asiri M; Tunio M; Al Hadab A; Mohamed R; Bayoumi Y; Al Saeed E; Al Arifi M; Al Amro A
Ann Saudi Med; 2013; 33(4):327-33. PubMed ID: 24060709
[TBL] [Abstract][Full Text] [Related]
58. Impact of treatment time and dose escalation on local control in locally advanced cervical cancer treated by chemoradiation and image-guided pulsed-dose rate adaptive brachytherapy.
Mazeron R; Castelnau-Marchand P; Dumas I; del Campo ER; Kom LK; Martinetti F; Farha G; Tailleur A; Morice P; Chargari C; Lefkopoulos D; Haie-Meder C
Radiother Oncol; 2015 Feb; 114(2):257-63. PubMed ID: 25497872
[TBL] [Abstract][Full Text] [Related]
59. Preoperative Chemoradiotherapy in Locally Advanced Bulky Squamous Cell Carcinoma of the Uterine Cervix.
Nakao Y; Hashiguchi M; Nishiyama S; Aihara S; Iwasaka T; Yokoyama M
Int J Gynecol Cancer; 2017 Nov; 27(9):1943-1948. PubMed ID: 28786876
[TBL] [Abstract][Full Text] [Related]
60. Concurrent Chemo- Radiobrachytherapy with Cisplatin and Medium Dose Rate Intra- Cavitary Brachytherapy for Locally Advanced Uterine Cervical Cancer.
Aghili M; Andalib B; Karimi Moghaddam Z; Maddah Safaie A; Amoozgar Hashemi F; Mousavi Darzikolaie N
Asian Pac J Cancer Prev; 2018 Oct; 19(10):2745-2750. PubMed ID: 30360600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
